A detailed history of Camden Capital, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Camden Capital, LLC holds 658 shares of MCK stock, worth $383,844. This represents 0.03% of its overall portfolio holdings.

Number of Shares
658
Previous 1,019 35.43%
Holding current value
$383,844
Previous $471,000 25.05%
% of portfolio
0.03%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$473.42 - $539.26 $170,904 - $194,672
-361 Reduced 35.43%
658 $353,000
Q4 2023

Feb 05, 2024

BUY
$437.42 - $470.64 $445,730 - $479,582
1,019 New
1,019 $471,000
Q2 2022

Aug 03, 2022

SELL
$300.57 - $336.42 $50,796 - $56,854
-169 Reduced 9.08%
1,693 $553,000
Q1 2022

May 06, 2022

BUY
$244.61 - $310.48 $76,073 - $96,559
311 Added 20.05%
1,862 $570,000
Q4 2021

Feb 28, 2022

SELL
$198.21 - $248.9 $165,703 - $208,080
-836 Reduced 35.02%
1,551 $385,000
Q4 2021

Feb 14, 2022

BUY
$198.21 - $248.9 $9,315 - $11,698
47 Added 2.01%
2,387 $593,000
Q3 2021

Nov 03, 2021

BUY
$188.42 - $208.66 $6,783 - $7,511
36 Added 1.56%
2,340 $467,000
Q2 2021

Aug 16, 2021

BUY
$184.89 - $202.68 $34,759 - $38,103
188 Added 8.88%
2,304 $441,000
Q1 2021

May 10, 2021

BUY
$169.52 - $196.53 $5,763 - $6,682
34 Added 1.63%
2,116 $413,000
Q4 2020

Feb 04, 2021

SELL
$143.79 - $183.66 $27,176 - $34,711
-189 Reduced 8.32%
2,082 $362,000
Q3 2020

Oct 30, 2020

SELL
$140.89 - $159.9 $986 - $1,119
-7 Reduced 0.31%
2,271 $338,000
Q2 2020

Aug 11, 2020

BUY
$125.49 - $164.68 $27,607 - $36,229
220 Added 10.69%
2,278 $350,000
Q1 2020

Apr 13, 2020

SELL
$115.75 - $170.96 $10,533 - $15,557
-91 Reduced 4.23%
2,058 $278,000
Q4 2019

Feb 10, 2020

BUY
$130.23 - $153.27 $279,864 - $329,377
2,149 New
2,149 $297,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.8B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.